1 not yet recruiting, 1 recruiting. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Not yet recruiting 1, Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Neoadjuvant Chemoimmunotherapy: new trials by email Literature Review of Neoadjuvant Chemoimmunotherapy trials Research Report on Neoadjuvant Chemoimmunotherapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neoadjuvant SF-SBRT Plus Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC. Stereotactic body radiotherapy (SBRT), neoadjuvant immunotherapy, Neoadjuvant Chemotherapy - Non Small Cell Lung Cancer, Stereotactic Body Radiotherapy | Phase 3 | Not yet recruiting | Shanghai Pulmonary Hospital, Shanghai, China | 201 | 2026-05-01 | 2026-05-29 |
| Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC Camrelizumab, Cisplatin, Nab paclitaxel - Cervical Cancer, Locally Advanced Cervical Cancer | Phase 2 / Phase 3 | Recruiting | Tongji Hospital | 440 | 2024-04-22 | 2024-10-30 |
Carcinoma, Non-Small-Cell Lung (1) · Uterine Cervical Neoplasms (1)
Neoplasms (2) · Neoplasms by Site (2) · Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Neoplasms, Female (1) · Lung Diseases (1) · Lung Neoplasms (1) · Respiratory Tract Diseases (1) · Respiratory Tract Neoplasms (1) · Thoracic Neoplasms (1) · Urogenital Diseases (1)
Brachytherapy (1) · Cisplatin (1) · Neoadjuvant Therapy (1) · Radiosurgery (1) · Taxes (1) · camrelizumab (1)
Shanghai Pulmonary Hospital, Shanghai, China (1) · Tongji Hospital (1)
China (1)
Ding Ma (1)